Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit V Desai

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|February 10, 2017
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosisLaura L Kovanda, Amit V Desai, William W Hope
Lab on a Chip|February 4, 2012
Design considerations for electrostatic microvalves with applications in poly(dimethylsiloxane)-based microfluidicsAmit V Desai, Joshua D Tice, Christopher A Apblett, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
No Dose Adjustment for Isavuconazole Based on Age or SexAmit V Desai, David Han, Donna L Kowalski, et al.
Lab on a Chip|October 14, 2010
Microfluidic labeling of biomolecules with radiometals for use in nuclear medicineTobias D Wheeler, Dexing Zeng, Amit V Desai, et al.
Nuclear Medicine and Biology|October 20, 2012
Microfluidic radiolabeling of biomolecules with PET radiometalsDexing Zeng, Amit V Desai, David Ranganathan, et al.
Biomicrofluidics|November 8, 2014
Microfluidic platform for the study of intercellular communication via soluble factor-cell and cell-cell paracrine signalingMatthew B Byrne, Lisa Trump, Amit V Desai, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)Laura L Kovanda, Amit V Desai, Qiaoyang Lu, et al.
European Journal of Clinical Pharmacology|March 9, 2017
Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokineticsRobert W Townsend, Shahzad Akhtar, Harry Alcorn, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2019
Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy SubjectsLaura L Kovanda, Sean M Sullivan, Larry R Smith, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2013
Cell-laden hydrogels in integrated microfluidic devices for long-term cell culture and tubulogenesis assaysNathan P Gabrielson, Amit V Desai, Bhushan Mahadik, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|February 10, 2017
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosisLaura L Kovanda, Amit V Desai, William W Hope
Lab on a Chip|February 4, 2012
Design considerations for electrostatic microvalves with applications in poly(dimethylsiloxane)-based microfluidicsAmit V Desai, Joshua D Tice, Christopher A Apblett, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
No Dose Adjustment for Isavuconazole Based on Age or SexAmit V Desai, David Han, Donna L Kowalski, et al.
Lab on a Chip|October 14, 2010
Microfluidic labeling of biomolecules with radiometals for use in nuclear medicineTobias D Wheeler, Dexing Zeng, Amit V Desai, et al.
Nuclear Medicine and Biology|October 20, 2012
Microfluidic radiolabeling of biomolecules with PET radiometalsDexing Zeng, Amit V Desai, David Ranganathan, et al.
Biomicrofluidics|November 8, 2014
Microfluidic platform for the study of intercellular communication via soluble factor-cell and cell-cell paracrine signalingMatthew B Byrne, Lisa Trump, Amit V Desai, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)Laura L Kovanda, Amit V Desai, Qiaoyang Lu, et al.
European Journal of Clinical Pharmacology|March 9, 2017
Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokineticsRobert W Townsend, Shahzad Akhtar, Harry Alcorn, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2019
Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy SubjectsLaura L Kovanda, Sean M Sullivan, Larry R Smith, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2013
Cell-laden hydrogels in integrated microfluidic devices for long-term cell culture and tubulogenesis assaysNathan P Gabrielson, Amit V Desai, Bhushan Mahadik, et al.
Pageof 2